Canicon: Caniheart-BZ 5 - Pimobendan & Benazepril Tablets
No return & Exchange Available
Caniheart-BZ 5 - Pimobendan & Benazepril Tablets for Advanced Canine Cardiac Care
Caniheart-BZ 5 combines two proven cardiac medications - Pimobendan and Benazepril - in convenient chewable tablets specifically formulated for comprehensive heart failure management in dogs. This dual-action therapy addresses multiple aspects of cardiac dysfunction for optimal treatment outcomes.
Key Features
- Dual-Action Cardiac Therapy: Combines positive inotropic support with ACE inhibition for comprehensive heart failure management.
 - Easy Chew Format: Palatable tablets designed for stress-free administration and improved compliance.
 - Veterinary-Specific Formulation: Precisely dosed for canine patients with heart conditions.
 
Active Ingredients
- Pimobendan: Positive inotrope and vasodilator that strengthens heart contractions while reducing cardiac workload
 - Benazepril: ACE inhibitor that reduces blood pressure and decreases strain on the failing heart
 
Primary Indications
- Congestive Heart Failure (CHF) in dogs
 - Dilated Cardiomyopathy management
 - Mitral Valve Disease with heart failure
 - Combination therapy for advanced cardiac conditions
 - Quality of life improvement in cardiac patients
 
Product Specifications
- Pack Size: 30 tablets
 - Target Species: Dogs only
 - Form: Easy-chew tablets
 - Manufacturer: Canicon
 - Classification: Prescription veterinary medication (Rx)
 
Therapeutic Benefits
- Enhanced Cardiac Output through dual mechanism action
 - Reduced Cardiac Workload via ACE inhibition
 - Improved Exercise Tolerance and activity levels
 - Better Quality of Life for dogs with heart failure
 - Convenient Combination Therapy in single tablet
 - Excellent Palatability ensuring medication compliance
 
Suitable For
- Dogs with diagnosed congestive heart failure
 - Canines with mitral valve insufficiency
 - Dogs requiring combination cardiac therapy
 - Patients needing both inotropic and afterload reduction
 - Long-term cardiac condition management
 
Prescription Required: Must be prescribed by a qualified veterinarian following cardiac evaluation.
Species-Specific: Formulated specifically for dogs - not suitable for cats.